Deutsche Bank Ag\ Merus N.V. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Merus N.V. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 112,640 shares of MRUS stock, worth $5.59 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

112,640

Previous 110,881 1.59%

Holding current value

$5.59 Million

Previous $6.56 Million 14.22%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$47.19 - $58.84 $83,007 - $103,499	1,759 Added 1.59%	112,640 $5.63 Million
Q2 2024 Aug 14, 2024	SELL	$39.81 - $60.2 $48,608 - $73,504	-1,221 Reduced 1.09%	110,881 $6.56 Million
Q1 2024 May 15, 2024	SELL	$28.03 - $51.82 $12,641 - $23,370	-451 Reduced 0.4%	112,102 $5.05 Million
Q4 2023 Feb 14, 2024	BUY	$20.06 - $28.66 $4,734 - $6,763	236 Added 0.21%	112,553 $3.1 Million
Q2 2023 Aug 14, 2023	SELL	$18.33 - $27.18 $52,790 - $78,278	-2,880 Reduced 2.5%	112,317 $2.96 Million
Q1 2023 May 15, 2023	BUY	$14.25 - $20.5 $1.6 Million - $2.3 Million	112,317 Added 3899.9%	115,197 $2.12 Million
Q4 2022 Feb 13, 2023	BUY	$12.8 - $23.66 $36,864 - $68,140	2,880 New	2,880 $44,000
Q3 2021 Nov 04, 2021	SELL	$16.48 - $27.23 $6.42 Million - $10.6 Million	-389,668 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$20.0 - $25.48 $492,860 - $627,903	-24,643 Reduced 5.95%	389,668 $8.21 Million
Q1 2021 May 13, 2021	BUY	$16.14 - $29.11 $3.52 Million - $6.34 Million	217,910 Added 110.95%	414,311 $8.65 Million
Q4 2020 Feb 16, 2021	BUY	$11.4 - $18.36 $1.79 Million - $2.89 Million	157,170 Added 400.63%	196,401 $3.44 Million
Q3 2020 Nov 12, 2020	SELL	$10.57 - $16.0 $2.14 Million - $3.24 Million	-202,703 Reduced 83.78%	39,231 $471,000
Q2 2020 Aug 13, 2020	BUY	$10.5 - $17.36 $2.54 Million - $4.2 Million	241,934 New	241,934 $3.89 Million
Q3 2019 Nov 14, 2019	SELL	$14.55 - $20.52 $98,096 - $138,345	-6,742 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$12.93 - $16.83 $119,705 - $155,812	-9,258 Reduced 57.86%	6,742 $98,000
Q1 2019 May 15, 2019	BUY	$11.09 - $15.83 $177,440 - $253,280	16,000 New	16,000 $236,000
Q4 2018 Feb 14, 2019	SELL	$11.46 - $20.81 $198,544 - $360,533	-17,325 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$18.47 - $26.39 $450,594 - $643,810	-24,396 Reduced 58.47%	17,325 $341,000
Q2 2018 Aug 14, 2018	BUY	$16.77 - $22.76 $120,022 - $162,893	7,157 Added 20.71%	41,721 $949,000
Q1 2018 May 15, 2018	BUY	$16.07 - $19.87 $404,385 - $500,008	25,164 Added 267.7%	34,564 $640,000
Q4 2017 Feb 14, 2018	BUY	$14.23 - $21.28 $79,517 - $118,912	5,588 Added 146.59%	9,400 $182,000
Q3 2017 Nov 14, 2017	BUY	$13.6 - $19.87 $51,843 - $75,744	3,812	3,812 $75,000

Others Institutions Holding MRUS

# of Institutions

200

Shares Held

61.9M

Call Options Held

243K

Put Options Held

300K

View Full List

About Merus N.V.

Ticker MRUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,878,200
Market Cap $2.28B
Description
Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...

More about MRUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account